FeaturesSignalPricingFounders
Log inGet started free
UB

Uppsala Bio

AcceleratorQuiet

BIO-X is an early-stage life science commercialization program which uses project calls to select and fund potential services to specific healthcare and society needs. It follows industrial-standard selection and development models to ensure that funding and support goes to projects that possess the potential to meet high scientific, technical and industrial requirements, as well as clearly defined healthcare needs in terms of clinical utility, long-term patient value and cost-efficiency. It receives public funding from the European Regional Development Fund and VINNOVA (the Swedish Governmental Agency for Innovation Systems).

SwedenFounded 2012lifescience.stuns.se/
0
Investments
0
Exits
AUM
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Uppsala Bio.

Get started free

Investment Thesis & Strategy

Uppsala Bio, as an accelerator, invests in early-stage biotech, healthcare, pharmaceutical, and medical device companies with the potential to meet high scientific, technical, and industrial requirements, as well as clearly defined healthcare needs. They provide funding and support to projects that demonstrate clinical utility, long-term patient value, and cost-efficiency.

Frequently Asked Questions

Uppsala Bio focuses on Pre-seed, Seed stage investments.

Related Investors